Skip to main content
Quest Diagnostics

Performance of a Dual-Target Measles Assay for Detection and Vaccine Differentiation

PASCV 2026

Pan American Society for Clinical Virology

Clearwater Beach, FL April 29-May 1, 2026

Poster presentation: Performance of a Dual-Target Measles Assay for Detection and Vaccine Differentiation

Authors: Shates T, Realegeno SE, Marlowe EM

Medical Specialty: Infectious disease

Related content

Test FAQ
Measles (Rubeola)
Publication
Multiomic Immune Profiling of Pediatric Transplant Recipients Identifies Cell States Associated with Vaccine Response
Conference Presentation
Performance of an Automated Measles Virus Real Time RT-PCR Assay from Upper Respiratory Specimens using the Panther Fusion
Conference Presentation
Performance of a Qualitative Real-Time RT-PCR Assay for Measles Virus
Publication
Proceedings of the Clinical Microbiology Open 2023: Discussions About Pandemic Preparedness

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.